Until now, a common treatment is to use steroid inhalers that suppress inflammation and other inhalers that expand the bronchial tubes when symptoms occur. Some inhalers on the market offer both treatments.
With the medical device that became covered by public insurance in April, a tube is inserted from the mouth into the bronchial tubes and warms them so that they expand. First, a tube that is about 5 millimeters in diameter reaches the bronchial tubes, then an even thinner tube is inserted through the first tube. An electrode at the end of the thin tube is used to warm the bronchial tubes to 65 C for 10 seconds. This causes the swollen muscle tissue of the bronchial tubes to shrink and allow air to more easily pass through.
The treatment is limited to patients with severe symptoms who are 18 or older and for whom other treatments have been ineffective. The treatment is administered on three occasions separated by intervals of at least three weeks, one time each for the lower right lung, the lower left lung, and the upper parts of both lungs. On each occasion, the device is used to warm up 40 to 70 locations, taking about an hour.
A study team comprising members from the United States, Britain, Canada and others followed 162 patients for five years after receiving the treatment and found that the frequency of attacks declined by about half compared to before the treatment. The frequency of visiting the emergency outpatient unit at hospitals also declined by about 80 percent compared to before the treatment.
This treatment has just been introduced in Japan. It does not completely cure asthma, so patients must continue to take medicine even after receiving this treatment.
“In the future, I would like to verify whether patients could actually stop taking medicine after treatment,” said Yuji Toda, professor in the Department of Respiratory Medicine and Allergology at Kinki University’s Faculty of Medicine in Osaka Prefecture.
“One condition to use this medial device is that patients are only allowed to undergo this treatment once in their lives. The timing of the treatment should be determined in consultation with a doctor,” said Haruhito Sugiyama, chief director of the Department of Respiratory Medicine at the National Center for Global Health and Medicine in Tokyo. During the treatment, because a tube is inserted into the bronchial tubes, space through which air can flow becomes restricted. For this reason, patients with particularly low lung function may not be able to receive the treatment.
For hospitals to provide this treatment, doctors with vast knowledge and experience with asthma need to be trained by the device’s manufacturer.
In addition to the National Center for Global Health and Medicine and Kinki University Hospital, the treatment is available at such institutions as Dokkyo Medical University in Tochigi Prefecture, the National Hospital Organization Tokyo National Hospital in Tokyo and the National Hospital Organization Nagoya Medical Center in Aichi Prefecture.
While treatment of asthma is evolving, it remains essential to prevent attacks and the worsening of the condition. Carefully cleaning the house is important to avoid asthma triggers such as dust, dust mites, mold and animal hairs.